absence (petit-mal) seizure

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • age 3-15 years
  • uncommon in adults (not in adults)[3]

Pathology

Clinical manifestations

* memory problems, confusion, falls, dizziness, numbness (presumptively absence seizure)[5]

Laboratory

Differential diagnosis

Management

More general terms

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 1034-35
  2. 2.0 2.1 Alan Gelb, UCSF, Department of Emergency Services, San Francisco General Hospital, 1998
  3. 3.0 3.1 3.2 Medical Knowledge Self Assessment Program (MKSAP) 11, 16. 17. 18, 19. American College of Physicians, Philadelphia 1998, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  4. 4.0 4.1 Glauser TA et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010 Mar 4; 362:790. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20200383
    Vining EPG. Ethosuximide in childhood absence epilepsy - Older and better. N Engl J Med 2010 Mar 4; 362:843. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20200390
  5. 5.0 5.1 5.2 NEJM Knowledge+ Neurology
  6. NEJM Knowledge+ Psychiatry
  7. Epilepsy and Seizures in Older Adults https://www.cdc.gov/epilepsy/communications/features/olderadults.htm